Pathways to ensure universal and affordable access to hepatitis C treatment

Direct-acting antivirals (DAAs) have dramatically changed the landscape of hepatitis C treatment and prevention. The World Health Organization has called for the elimination of hepatitis C as a public health threat by 2030. However, the discrepancy in DAA prices across low-, middle- and high-income...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Med
Main Authors: Douglass, Caitlin H., Pedrana, Alisa, Lazarus, Jeffrey V., ‘t Hoen, Ellen F. M., Hammad, Radi, Leite, Ricardo Baptista, Hill, Andrew, Hellard, Margaret
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Debate
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6176525/
https://ncbi.nlm.nih.gov/pubmed/30296935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1162-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados